A Review Of pentobarbital sodium use
A Review Of pentobarbital sodium use
Blog Article
pentobarbital will minimize the level or effect of nateglinide by influencing hepatic enzyme CYP2C9/ten metabolism. Use Caution/Watch.
pentobarbital will reduce the extent or effect of dienogest/estradiol valerate by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Women of all ages should not decide on estradiol valerate/dienogest as their contraceptive even though employing sturdy CYP3A4 inducers as a result of likely minimize in contraceptive efficacy.
pentobarbital will lower the level or effect of docetaxel by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Significance Unfamiliar.
buprenorphine, extended-performing injection and pentobarbital equally increase sedation. Stay clear of or Use Alternate Drug. Limit use to clients for whom alternative remedy options are insufficient
Phenytoin, sodium valproate, valproic acid: The effect of barbiturates around the metabolism of phenytoin appears to become variable. Some investigators report an accelerating effect, whilst others report no effect. Because the effect of barbiturates within the metabolism of phenytoin is not predictable, phenytoin and barbiturate blood degrees should be monitored more commonly if these drugs are given concurrently.
pentobarbital will minimize the level or effect of meloxicam by impacting hepatic enzyme CYP2C9/ten metabolism. Slight/Significance Unidentified.
Monoamine oxidase inhibitors (MAOI): MAOI prolong the effects of barbiturates almost certainly because metabolism in the barbiturate is inhibited.
pentobarbital will decrease the extent or effect of isavuconazonium sulfate by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated.
Doxycycline: Phenobarbital has been revealed to shorten the half-life of doxycycline for so long as 2 months following barbiturate therapy is discontinued.
pentobarbital will lessen the level or effect of loratadine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch.
pentobarbital will lower the level or effect of rolapitant by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. Long-time period coadministration of powerful CYP3A4 inducers with rolapitant may appreciably decrease rolapitant efficacy.
pentobarbital will decrease the level or effect of quinidine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on.
pentobarbital will reduce the extent or effect click here of elbasvir/grazoprevir by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. The therapeutic effect of elbasvir/grazoprevir can be diminished if coadministered with solid CYP3A inducers and is thus contraindicated.
pentobarbital will decrease the extent or effect of imatinib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Importance Unfamiliar.